The European Insomnia Guideline: An Update on the Diagnosis and Treatment of Insomnia 2023

On 12 December 2023, at 16:00 CET (15:00 GMT), we invite you to join us for the webinar ‘The European Insomnia Guideline: An Update on the Diagnosis and Treatment of Insomnia 2023.’

Sleep is undeniably a cornerstone of our well-being, with a profound impact on our physical and mental health. Moderator, Prof. Dr. Dieter Riemann, accompanied by co-authors Prof. Dr. Tiina Paunio (Finland), Prof. Dr. Colin Espie (United Kingdom) and Prof. Dr. Chiara Baglioni (Germany) of the European Insomnia Guideline, will explore the latest insights into insomnia and its treatment.

Key topics to be covered:

• Diagnostic Procedure: Clinical interview, sleep questionnaires, and diaries, with the option of actigraphy for specific purposes.
• Polysomnography: Essential for evaluating various sleep disorders, treatment-resistant insomnia, and other indications.
• First-line Treatment: Cognitive-behavioural therapy, applied in-person or digitally, with pharmacological intervention if needed.
• Short-term Treatment Options: Benzodiazepines, benzodiazepine receptor agonists, daridorexant, and low-dose sedating antidepressants.
• Longer-Term Considerations: Depending on advantages and disadvantages, longer-term treatment may be initiated in some cases.
• Orexin Receptor Antagonists: Recommended for periods of up to 3 months or longer.
• Prolonged-Release Melatonin: Suitable for up to 3 months in patients aged 55 years and above.
• Not Recommended: Antihistaminergic drugs, antipsychotics, fast-release melatonin, ramelteon, and phytotherapeutics.
• Adjunct Therapies: Light therapy and exercise interventions may be useful alongside cognitive-behavioural therapy for insomnia.

With their extensive experience in sleep research and medicine, our speakers promise an engaging and informative session.